Page 2 - Nasdaq Cmpi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brokerages expect Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI – Get Rating) to report earnings of ($0.73) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Checkmate Pharmaceuticals’ earnings. Checkmate Pharmaceuticals reported earnings per share of ($0.65) during the same quarter last year, which indicates a negative year-over-year growth rate of […]

Checkmate Pharmaceuticals (NASDAQ:CMPI – Get Rating) announced its quarterly earnings results on Tuesday. The company reported ($0.62) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.74) by $0.12, Fidelity Earnings reports. NASDAQ:CMPI traded up $0.01 on Thursday, hitting $3.22. The stock had a trading volume of 10,192 shares, compared to its […]

CAMBRIDGE, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical...